Cabozantinib for treating medullary thyroid cancer (TA516)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2018
Eneboparatide for treating chronic hypoparathyroidism [ID6532]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Eneboparatide for treating chronic hypoparathyroidism [TSID12145]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
High-intensity focused ultrasound for symptomatic benign thyroid nodules (HTG504)Product type:GuidanceProgramme:HealthTech guidancePublished: 27 February 2019
Intraoperative nerve monitoring during thyroid surgery (HTG164)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 March 2008
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (TA535)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 August 2018
Minimally invasive video-assisted thyroidectomy (HTG349)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 August 2014
Percutaneous Laser Ablation (PLA) for benign thyroid nodulesStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (HTG646)Product type:GuidanceProgramme:HealthTech guidancePublished: 16 November 2022
Retrobulbar irradiation for thyroid eye disease (HTG94)Product type:GuidanceProgramme:HealthTech guidancePublished: 14 December 2005
Satralizumab for treating thyroid eye disease [ID6648]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teprotumumab for treating thyroid eye disease [ID6432]Status:DeferredProgramme:Technology appraisal guidanceExpected publication date: TBC
Thyroid disease: assessment and management (NG145)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 October 2023Published: 20 November 2019
Transoral Endoscopic Thyroid/Parathyroid Vestibular ApproachStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Transoral endoscopic thyroid surgery via a vestibular approachStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (HTG416)Product type:GuidanceProgramme:HealthTech guidancePublished: 22 June 2016
Vandetanib for treating medullary thyroid cancer (TA550)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 December 2018
Veligrotug for treating thyroid eye disease [ID6636]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC